Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cassiopea Wins With Winlevi Acne Phase III Data

Jul 10 2018

• By Kevin Grogan

SC1807_Hiding Face_387608575_1200.jpg — Cassiopea Unveils Strong Data • Source: Shutterstock

Related Content

Dermira Ends Acne Program After Phase III Failure, Tries To Keep Focus On Hyperhidrosis Drug

Mar 06 2018

Related Companies

Cassiopea S.p.A.

Cosmo Pharmaceuticals N.V.

Additional Topics

Clinical Trials Research & Development Dermatology BioPharmaceutical

More from Dermatological

More from Therapeutic Category

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.